Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools. While the traditional staging systems, such as the TNM classification, focus on anatomical factors, they fall…
Continue Reading
News Source: medicalxpress.com
Leave a Reply